These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33529163)

  • 1. A little help from residual β cells has long-lasting clinical benefits.
    Lam A; Dayan C; Herold KC
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia.
    Gubitosi-Klug RA; Braffett BH; Hitt S; Arends V; Uschner D; Jones K; Diminick L; Karger AB; Paterson AD; Roshandel D; Marcovina S; Lachin JM; Steffes M; Palmer JP;
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
    Steffes MW; Sibley S; Jackson M; Thomas W
    Diabetes Care; 2003 Mar; 26(3):832-6. PubMed ID: 12610045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.
    Jeyam A; Colhoun H; McGurnaghan S; Blackbourn L; McDonald TJ; Palmer CNA; McKnight JA; Strachan MWJ; Patrick AW; Chalmers J; Lindsay RS; Petrie JR; Thekkepat S; Collier A; MacRury S; McKeigue PM;
    Diabetes Care; 2021 Feb; 44(2):390-398. PubMed ID: 33303639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 Diabetes.
    Lanctôt SO; Lovblom LE; Lewis EJH; Morris M; Cardinez N; Scarr D; Bakhsh A; Abuabat MI; Lovshin JA; Lytvyn Y; Boulet G; Bussières A; Brent MH; Paul N; Bril V; Cherney DZI; Perkins BA
    Can J Diabetes; 2024 Mar; 48(2):89-96. PubMed ID: 37944665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic shear wave elastography in children with type 1 diabetes: relation to diabetes duration, glycemic indices, fasting C-peptide and diabetic complications.
    Salah NY; Madkour SS; Soliman KS
    Pediatr Radiol; 2022 Nov; 52(12):2348-2358. PubMed ID: 35460036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.
    Gubitosi-Klug RA;
    Diabetes Care; 2014; 37(1):44-9. PubMed ID: 24356597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During Hypoglycemia.
    Zenz S; Regittnig W; Boulgaropoulos B; Augustin T; Brunner M; Korsatko S; Münzker J; Narath SH; Raml R; Magnes C; Pieber TR
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3583-e3593. PubMed ID: 35833597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
    Sherr J; Tamborlane WV; Xing D; Tsalikian E; Mauras N; Buckingham B; White NH; Arbelaez AM; Beck RW; Kollman C; Ruedy K;
    Diabetes Care; 2012 Apr; 35(4):817-20. PubMed ID: 22323414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible?
    Henriksen MM; Færch L; Thorsteinsson B; Pedersen-Bjergaard U
    J Diabetes Sci Technol; 2016 Nov; 10(6):1230-1235. PubMed ID: 27651425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Residual β-cell Function in Chinese Patients With Autoimmune Type 1 Diabetes.
    Wang Y; Qin Y; Gu H; Zhang L; Wang J; Huang Y; Shi Y; Hu Q; Chen Y; Gu Y; Shi Y; Tao Y; Zhang M
    J Clin Endocrinol Metab; 2022 May; 107(6):e2348-e2358. PubMed ID: 35218654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Feb; 46(2):271-86. PubMed ID: 9000705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.